Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSysgroup Regulatory News (SYS)

Share Price Information for Sysgroup (SYS)

Share Price is delayed by 15 minutes
Get Live Data
18.00    0.00 (0.00%)
Bid:
17.00
Ask:
19.00
Spread: 2.00 (11.765%)
Market Cap: £15.07m
SYS Live PriceLast checked at - London Stock Exchange

Intraday Sysgroup Share Chart

Trading Statement

27 Nov 2008 07:00

RNS Number : 0390J
System C Healthcare plc
27 November 2008
 



System C Healthcare plc 

Pre-Close Trading Update

System C Healthcare plc (AIM: SYS) ("the Company"), a leading provider of information solutions and services to the healthcare sector, is pleased to provide the following trading update for the six months ending 30 November 2008, prior to entering its close period. As at 31 May 2008, net cash balances stood at £12.4 million. Since that date, revenues, profit and cash have continued to grow as forecast, and the Company is on track to meet consensus market expectations for the full year. 

Services

National demand for System C's expert services remains strong in both the public and private healthcare sectors. Activity continues to increase in the Company's traditional stronghold areas of deployment support and problem resolution. Its presence in specialist areas such as clinical design and business intelligence also continues to grow.

Products

The product division has performed well over the half year, with successful deployments of Medway Sigma, Eclipse Maternity, Sigma BI and IQUtopia. All the product development teams are now working towards a common code-set, and it is expected that the entire product range will be available under a single Medway Sigma banner by the end of the first half of the 2009 calendar year.

System C's CEO, Dr Ian Denley, said "We are continuing to build on our reputation for high quality delivery and are reaping the benefits of that work. An increase in new product opportunities, coupled with sustained demand for deployment services and the potential for growth by selective acquisition, are encouraging signs for 2009 and beyond." 

For further information please contact:

System C Healthcare plc

Dr Ian Denley, Chief Executive

Andrew Coll, Finance Director

Tel: 01622 691 616

Maitland

Emma Burdett

Richard Farnsworth 

Tel: 020 7379 5151

Collins Stewart Europe Limited

Mark Connelly

Tel: 020 7523 8350

Notes to editors 

System C Healthcare plc (http://www.systemc.com/), established in 1983, specialises in the provision of information systems and solutions to the healthcare sector. Its team of professionals has an average of 15 years' healthcare experience and can provide all aspects of systems design, development and deployment services. System C is founded upon the belief that IT solutions, when effectively implemented, can significantly contribute towards improving patient care.

System C is a specialist developer and supplier of Patient Administration and Electronic Patient Record Systems to the health service. The Group's MedWay product is successfully installed at a number of NHS hospitals including Noble's Hospital Isle of Man, University Hospitals Aintree, Swindon and Marlborough NHS Trust, Tameside Hospitals NHS Trust and the Christie, one of the UK's leading cancer hospitals.

System C has helped to install healthcare systems at over 150 NHS Trusts and offers a wide range of services to the NHS, other healthcare providers and third-party suppliers. Services include programme/project/change management, design, build and test, implementation, training, data migration, interfacing and helpdesk/support services. Within the National Programme for IT (NPfIT), System C people have been involved in 75% of secondary care go-lives to date as well as many GP, community, Single Assessment Programme and child health deployments.

System C hold NHS product and services framework contracts in the following categories:

Patient Administration Systems (PAS) 

Maternity systems 

Ambulance systems 

Urgent care (Accident and Emergency) 

Theatres 

Order communications and results reporting 

ePrescribing 

Pharmacy stock control 

Social care 

Integrated care pathways and care planning 

Diabetes 

Oncology services 

Clinical integration and systems integration services 

Respiratory care 

Elderly care 

Consultancy services 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBIBDBCUDGGIL
Date   Source Headline
19th May 20267:00 amRNSChange of Registered Office
13th Apr 20267:00 amRNSYear End Trading Update
13th Mar 202610:11 amRNSTransfer of Shares to AI Board Adviser and TVR
13th Mar 202610:11 amRNSTransfer of Shares to AI Board Adviser and TVR
9th Feb 202610:15 amRNS-RIT Infrastructure Refresh Contract Win
3rd Feb 20264:13 pmRNSDirector/PDMR Dealing
29th Jan 20262:11 pmRNS-RContract win with the Scouts Association
22nd Jan 20269:34 amRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSAcquisition of Saxis Group Limited
22nd Dec 20252:08 pmRNSAcquisition of Saxis Group Limited
9th Dec 202512:06 pmRNS-RAppointment of AI Adviser
3rd Dec 20257:00 amRNSHalf Year Results to 30 September 2025
25th Nov 20257:00 amRNSNotice of Results
16th Sep 20253:38 pmRNSResult of AGM
12th Sep 202510:51 amRNSDirector Dealing
8th Sep 202512:17 pmRNSExercise of Options and Total Voting Rights
3rd Sep 20257:00 amRNSGrant of Options and PDMR Dealings
8th Aug 20257:00 amRNSNotice of AGM and Publication of Accounts
29th Jul 202510:17 amRNSDirector/PDMR Dealing
24th Jul 20257:00 amRNSFinal Results for the year ended 31 March 2025
14th Jul 20257:00 amRNSNotice of Results
29th Apr 20257:00 amRNSYear End Trading Update
20th Mar 202511:34 amRNS-RSysGroup Joins Rubrik's Advanced Partner Program
29th Jan 20259:17 amRNSHolding(s) in Company
28th Jan 20257:00 amRNSDirector/PDMR Dealing
22nd Jan 20257:00 amRNSHolding(s) in Company
19th Dec 202412:45 pmRNSExercise of Options and Total Voting Rights
4th Dec 20244:00 pmRNSPresentation via Investor Meet Company
3rd Dec 20241:00 pmRNSDirector/PDMR Dealing
3rd Dec 20247:00 amRNSHalf Year Results to 30 September 2024
19th Nov 20247:00 amRNSAcquisition & Notice of Results
20th Sep 202411:00 amRNSResult of AGM
12th Sep 20247:00 amRNSAIM Rule 17 and Schedule 2(g) Disclosure
3rd Sep 20247:00 amRNSGrant of Options and Director/PDMR Dealings
21st Aug 20244:50 pmRNSGrant of Options and Director/PDMR Dealings
15th Aug 20247:00 amRNSNotice of AGM and Publication of Annual Report
31st Jul 20247:00 amRNSFinal Results for the year ended 31 March 2024
24th Jul 20247:00 amRNSNotice of Results
28th Jun 202410:10 amRNSHolding(s) in Company
28th Jun 20247:00 amRNSHolding(s) in Company
24th Jun 20244:12 pmRNSResult of General Meeting and Total Voting Rights
14th Jun 20247:00 amRNSResult of Retail Offer
7th Jun 20248:00 amRNSLaunch of Retail Offer
7th Jun 20247:00 amRNSResult of Oversubscribed Placing and Subscription
6th Jun 20245:11 pmRNSProposed Fundraising
3rd Jun 20247:00 amRNSBoard Changes
29th May 20247:00 amRNSStrategic Partnership
30th Apr 20247:00 amRNSTrading Update
29th Feb 20248:49 amRNSHolding(s) in Company
29th Feb 20247:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.